Related Experiment Videos
Lymphedema of the lower extremities: evaluation by microcolloidal imaging
C M Intenzo1, A G Desai, S S Kim
1Department of Radiation Oncology and Nuclear Medicine, Thomas Jefferson University Hospital, Philadelphia, Pennsylvania 19107.
Clinical Nuclear Medicine
|February 1, 1989
Summary
Radionuclide lymphangiography offers a safe alternative to contrast lymphangiography for imaging lower extremity lymphatic systems. This study found technetium-99m antimony trisulfide colloid to be simple and effective for patients with lymphedema.
Area of Science:
- Radiology
- Nuclear Medicine
- Vascular Imaging
Background:
- Traditional contrast lymphangiography for lower extremity lymphatic imaging presents challenges.
- Potential side effects and procedural difficulties limit contrast lymphangiography.
Purpose of the Study:
- To evaluate radionuclide lymphangiography as a safe and reliable alternative.
- To assess the efficacy of technetium-99m antimony trisulfide colloid in imaging lymphedema.
Main Methods:
- Nine patients with lower extremity lymphedema were studied.
- Technetium-99m labeled to antimony trisulfide colloid was administered.
- Lymphatic imaging of the lower extremities was performed.
Main Results:
- Radionuclide lymphangiography was found to be a safe alternative.
- The procedure was relatively simple to perform.
- No adverse effects were observed in the patient group.
Conclusions:
- Radionuclide lymphangiography is a viable and safe imaging modality.
- Technetium-99m antimony trisulfide colloid is suitable for lymphatic imaging in lymphedema.
- This method offers a simpler approach compared to traditional techniques.